Trinity Biotech (TRIB) Long-Term Debt Issuances (2020 - 2022)
Historic Long-Term Debt Issuances for Trinity Biotech (TRIB) over the last 3 years, with Q2 2022 value amounting to -$80.0 million.
- Trinity Biotech's Long-Term Debt Issuances changed N/A to -$80.0 million in Q2 2022 from the same period last year, while for Mar 2022 it was $80.0 million, marking a year-over-year increase of 117331.32%. This contributed to the annual value of $30.2 million for FY2024, which is 50352.0% up from last year.
- Latest data reveals that Trinity Biotech reported Long-Term Debt Issuances of -$80.0 million as of Q2 2022.
- In the past 5 years, Trinity Biotech's Long-Term Debt Issuances registered a high of $80.0 million during Q1 2022, and its lowest value of -$80.0 million during Q2 2022.
- In the last 3 years, Trinity Biotech's Long-Term Debt Issuances had a median value of $3.1 million in 2020 and averaged $1.6 million.
- Data for Trinity Biotech's Long-Term Debt Issuances shows a peak YoY increase of 443599.77% (in 2022) and a maximum YoY decrease of 443599.77% (in 2022) over the last 5 years.
- Over the past 3 years, Trinity Biotech's Long-Term Debt Issuances (Quarter) stood at $4.5 million in 2020, then tumbled by 60.97% to $1.8 million in 2021, then tumbled by 4636.0% to -$80.0 million in 2022.
- Its Long-Term Debt Issuances was -$80.0 million in Q2 2022, compared to $80.0 million in Q1 2022 and $1.8 million in Q1 2021.